FNY Investment Advisers’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

FNY Investment Advisers’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,000	Closed	-$153K	–	814
2023 Q2	$153K	Buy	+4,000	New	+$103K	0.19%	83
2019 Q3	–	Sell	-1,200	Closed	-$9K	–	1232
2019 Q2	$9K	Buy	+1,200	New	+$18.3K	﹤0.01%	631

FNY Investment Advisers's KDNY Position: Q3 2023 in Review

FNY Investment Advisers sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 4,000 shares — an estimated $153K sold.

FNY Investment Advisers first reported a position in KDNY in Q2 2019 and held it in 2 quarters. The position peaked at $153K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

FNY Investment Advisers reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 4,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $153K.
FNY Investment Advisers first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
FNY Investment Advisers's Chinook Therapeutics, Inc. Common Stock position peaked at $153K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.